These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31742804)

  • 1. Exome sequencing identifies a FHOD3 p.S527del mutation in a Chinese family with hypertrophic cardiomyopathy.
    Huang S; Pu T; Wei W; Xu R; Wu Y
    J Gene Med; 2020 Mar; 22(3):e3146. PubMed ID: 31742804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variant Spectrum of Formin Homology 2 Domain-Containing 3 Gene in Chinese Patients With Hypertrophic Cardiomyopathy.
    Wu G; Ruan J; Liu J; Zhang C; Kang L; Wang J; Zou Y; Song L
    J Am Heart Assoc; 2021 Feb; 10(5):e018236. PubMed ID: 33586461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy.
    Ochoa JP; Sabater-Molina M; García-Pinilla JM; Mogensen J; Restrepo-Córdoba A; Palomino-Doza J; Villacorta E; Martinez-Moreno M; Ramos-Maqueda J; Zorio E; Peña-Peña ML; García-Granja PE; Rodríguez-Palomares JF; Cárdenas-Reyes IJ; de la Torre-Carpente MM; Bautista-Pavés A; Akhtar MM; Cicerchia MN; Bilbao-Quesada R; Mogollón-Jimenez MV; Salazar-Mendiguchía J; Mesa Latorre JM; Arnaez B; Olavarri-Miguel I; Fuentes-Cañamero ME; Lamounier A; Pérez Ruiz JM; Climent-Payá V; Pérez-Sanchez I; Trujillo-Quintero JP; Lopes LR; Repáraz-Andrade A; Marín-Iglesias R; Rodriguez-Vilela A; Sandín-Fuentes M; Garrote JA; Cortel-Fuster A; Lopez-Garrido M; Fontalba-Romero A; Ripoll-Vera T; Llano-Rivas I; Fernandez-Fernandez X; Isidoro-García M; Garcia-Giustiniani D; Barriales-Villa R; Ortiz-Genga M; García-Pavía P; Elliott PM; Gimeno JR; Monserrat L
    J Am Coll Cardiol; 2018 Nov; 72(20):2457-2467. PubMed ID: 30442288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletions of specific exons of FHOD3 detected by next-generation sequencing are associated with hypertrophic cardiomyopathy.
    Ochoa JP; Lopes LR; Perez-Barbeito M; Cazón-Varela L; de la Torre-Carpente MM; Sonicheva-Paterson N; De Uña-Iglesias D; Quinn E; Kuzmina-Krutetskaya S; Garrote JA; Elliott PM; Monserrat L
    Clin Genet; 2020 Jul; 98(1):86-90. PubMed ID: 32335906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy.
    Wooten EC; Hebl VB; Wolf MJ; Greytak SR; Orr NM; Draper I; Calvino JE; Kapur NK; Maron MS; Kullo IJ; Ommen SR; Bos JM; Ackerman MJ; Huggins GS
    Circ Cardiovasc Genet; 2013 Feb; 6(1):10-8. PubMed ID: 23255317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSRP3, p.Arg122*, is responsible for hypertrophic cardiomyopathy in a Chinese family.
    Huang H; Chen Y; Jin J; Du R; Tang K; Fan L; Xiang R
    J Gene Med; 2022 Jan; 24(1):e3390. PubMed ID: 34558151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel splice-site FHOD3 founder variant is a common cause of hypertrophic cardiomyopathy in the population of the Balkans-A cohort study.
    Vodnjov N; Toplišek J; Maver A; Čuturilo G; Jaklič H; Teran N; Višnjar T; Škrjanec Pušenjak M; Hodžić A; Miljanović O; Peterlin B; Writzl K
    PLoS One; 2023; 18(12):e0294969. PubMed ID: 38051749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-exome sequencing reveals a likely pathogenic LMNA variant causing hypertrophic cardiomyopathy.
    Mahdavi M; Mohsen-Pour N; Maleki M; Ghasemi S; Tabib A; Houshmand G; Naderi N; Masoumi T; Pouraliakbar H; Kalayinia S
    Lab Med; 2024 Jan; 55(1):62-70. PubMed ID: 37246508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel nonsense mutation in TNNT2 in a Chinese pedigree with hypertrophic cardiomyopathy: A case report.
    Gao G; Liu G; Chen W; Tong Y; Mao C; Liu J; Zhang X; He MM; Yang P
    Medicine (Baltimore); 2020 Aug; 99(34):e21843. PubMed ID: 32846832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel likely pathogenic TPM1 variant linked to hypertrophic cardiomyopathy in a family with sudden cardiac death.
    Azimi A; Soveizi M; Salmanipour A; Mozafarybazargany M; Ghaffari Jolfayi A; Maleki M; Kalayinia S
    ESC Heart Fail; 2024 Oct; 11(5):3180-3190. PubMed ID: 38874371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical exome sequencing unravels the diverse spectrum of genetic heterogeneity and genotype-phenotype correlations in hypertrophic cardiomyopathy.
    Harikrishnan S; Koshy L; Ganapathi S; Jeemon P; Ramya Das NK; Urulangodi M; Madhuma M; Vysakh Y; Subran A; Lakshmikanth LR
    Int J Cardiol; 2024 Sep; 411():132273. PubMed ID: 38880420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole exome sequencing combined with integrated variant annotation prediction identifies a causative myosin essential light chain variant in hypertrophic cardiomyopathy.
    Nomura A; Tada H; Teramoto R; Konno T; Hodatsu A; Won HH; Kathiresan S; Ino H; Fujino N; Yamagishi M; Hayashi K
    J Cardiol; 2016 Feb; 67(2):133-9. PubMed ID: 26443374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [P1208fs mutation in the cardiac myosin binding protein C is associated with hypertrophic cardiomyopathy in a Chinese pedigree].
    Li J; Liu LW; Na LS; Zuo L; Qi W; Liu Y; Shao H; Ma ZL; Wang LF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):321-6. PubMed ID: 27112610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediate-effect size p.Arg637Gln in
    Piqueras-Flores J; Villacorta-Argüelles E; Galvin J; Climent-Payá V; Escobar-López LE; Amor-Salamanca A; Garcia-Hernandez S; Esmonde S; Martínez-Del Río J; Soto-Pérez M; Garcia-Pavia P; Ochoa JP
    J Med Genet; 2024 Apr; 61(5):423-427. PubMed ID: 38160043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder.
    Li L; Bainbridge MN; Tan Y; Willerson JT; Marian AJ
    Circ Res; 2017 Mar; 120(7):1084-1090. PubMed ID: 28223422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation p.R1045H in MYH7 correlated with hypertrophic cardiomyopathy in a Chinese pedigree.
    Zhang Y; Shang Y; Liu L; Ding X; Wu H; Li L; Pang M
    BMC Med Genomics; 2021 Jul; 14(1):196. PubMed ID: 34330286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FLNC and MYLK2 Gene Mutations in a Chinese Family with Different Phenotypes of Cardiomyopathy.
    Qin X; Li P; Qu HQ; Liu Y; Xia Y; Chen S; Yang Y; Huang S; Wen P; Zhou X; Li X; Wang Y; Tian L; Hakonarson H; Wu Y; Zhuang J
    Int Heart J; 2021 Jan; 62(1):127-134. PubMed ID: 33455984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A de novo mutation of SMYD1 (p.F272L) is responsible for hypertrophic cardiomyopathy in a Chinese patient.
    Fan LL; Ding DB; Huang H; Chen YQ; Jin JY; Xia K; Xiang R
    Clin Chem Lab Med; 2019 Mar; 57(4):532-539. PubMed ID: 30205637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential digenic inheritance of familial hypertrophic cardiomyopathy identified by whole-exome sequencing.
    Ren MB; Chai XR; Li L; Wang X; Yin C
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1150. PubMed ID: 31960626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-exome sequencing identifies rare compound heterozygous mutations in the MYBPC3 gene associated with severe familial hypertrophic cardiomyopathy.
    Zhou N; Qin S; Liu Y; Tang L; Zhao W; Pan C; Qiu Z; Wang X; Shu X
    Eur J Med Genet; 2018 Aug; 61(8):434-441. PubMed ID: 29524613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.